* Amneal Pharmaceuticals Inc AMRX.OQ reported quarterly
adjusted
earnings of 16 cents per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of 19 cents. The mean expectation of four analysts for the
quarter was for earnings of 14 cents per share. Wall Street
expected results to range from 12 cents to 17 cents per share.
* Revenue rose 17.1% to $701.78 million from a year ago;
analysts
expected $658.14 million.
* Amneal Pharmaceuticals Inc's reported EPS for the quarter
was 2
cents.
* The company reported quarterly net income of $16.79
million.
* Amneal Pharmaceuticals Inc shares had risen by 22.4% this
quarter and gained 28.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4.4%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is "hold."
Wall Street's median 12-month price target for Amneal
Pharmaceuticals Inc is $8.00
This summary was machine generated from LSEG data August 9 at
02:21 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.14 0.16 Beat
Mar. 31 2024 0.09 0.14 Beat
Dec. 31 2023 0.09 0.14 Beat
Sep. 30 2023 0.13 0.19 Beat